6 completed, 1 terminated, 1 withdrawn. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 6, Terminated 1, Withdrawn 1 |
Follow Vilazodone: new trials by email Literature Review of Vilazodone trials Research Report on Vilazodone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vilazodone for Separation Anxiety Disorder Vilazodone, Placebo - Separation Anxiety Disorder | Phase 4 | Completed | New York State Psychiatric Institute | 24 | 2013-12-01 | 2018-03-07 |
| The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives Vilazodone, Citalopram - Major Depressive Disorder, Anxiety | Phase 4 | Withdrawn | Massachusetts General Hospital | 2013-04-01 | 2016-11-08 | |
| Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction? Vilazodone, Sertraline - Sexual Dysfunction, Major Depressive Disorder | Phase 4 | Terminated | Thomas Jefferson University | 4 | 2013-01-01 | 2016-08-25 |
| Vilazodone for the Treatment of Posttraumatic Stress Disorder Treatment (Viibryd) - PTSD, Depression | Phase 4 | Completed | Southern California Institute for Research and Education | 59 | 2012-10-01 | 2017-04-25 |
| Vilazodone for Treatment of Geriatric Depression Vilazodone; Viibryd, Paroxetine; Paxil - Major Depressive Disorder | Phase 4 | Completed | University of California, Los Angeles | 65 | 2012-07-01 | 2018-05-11 |
| Safety and Efficacy of Vilazodone in Major Depressive Disorder Placebo, Vilazodone - Major Depressive Disorder | Phase 4 | Completed | Forest Laboratories | 1219 | 2012-04-01 | 2015-05-18 |
| Safety and Efficacy of Vilazodone in Major Depressive Disorder Vilazodone, Placebo to citalopram, Placebo to vilazodone - Major Depressive Disorder | Phase 4 | Completed | Forest Laboratories | 1162 | 2011-12-01 | 2014-08-08 |
| Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder Dose-matched placebo, Vilazodone - Major Depressive Disorder | Phase 4 | Completed | Forest Laboratories | 518 | 2011-12-01 | 2014-04-03 |
Depressive Disorder, Major (6) · Depression (5) · Anxiety Disorders (2) · Anxiety, Separation (1) · Consciousness Disorders (1) · Depressive Disorder (1) · Sexual Dysfunction, Physiological (1) · Stress Disorders, Post-Traumatic (1)
Forest Laboratories (3) · Massachusetts General Hospital (1) · New York State Psychiatric Institute (1) · Southern California Institute for Research and Education (1) · Thomas Jefferson University (1) · University of California, Los Angeles (1)
United States (8) · Bulgaria (1) · Finland (1) · Germany (1) · Romania (1) · Russia (1) · Serbia (1) · Ukraine (1)
Carl Gommoll, MS (2) · Anita Clayton, MD (1) · Carrie Reichley (1) · Franklin Schneier, MD (1) · Helen Lavretsky, M.D. (1) · Michael E Henry, MD (1) · Michael Thase, MD (1) · Rajnish Mago, MD (1)
PMID 29608461, PMID 25396353, PMID 25470094, PMID 25500685, PMID 26039688, PMID 26693034, PMID 28858440, PMID 29071764